Subscribe to RSS Feed (Opens in New Window)
| 2009 | ||
| Tuesday, April 21st | ||
| 8:30 AM |
Introductory Remarks and Review of the Issues David B. Nash, MD, MBA, Thomas Jefferson University 8:30 AM - 8:45 AM |
|
|---|---|---|
| 8:45 AM |
Keynote Address: Follow-on Biologics: Getting Past the Exclusivity Debate Michael McCaughan, Editor-in-Chief, The Pink Sheet FDC/Windhover Biopharma Group 8:45 AM - 9:30 AM |
|
| 9:30 AM |
Regulatory Review and Approval Processes Under Current US Guidelines and Across the Globe Brian Harvey, MD, PhD., Vice President Regulatory Policy, sanofi-aventis 9:30 AM - 10:00 AM |
|
| 10:00 AM |
Regulatory Review and Approval Processes Under Current US Guidelines and Across the Globe Gundu H.R. Rao, PhD., Professor, Laboratory Medicine and Pathology, Lillehei Heart Institute, Institute for Engineering Medicine, University of Minnesota 10:00 AM - 10:30 AM |
|
| 10:45 AM |
Legislative Update- A comparison of Legislative Proposals and Implications Ann Witt, JD, Health Counsel to U.S. Congressman Henry Waxman 10:45 AM - 12:00 PM |
|
| 1:00 PM |
Geno J. Merli, MD, Professor of Medicine, Jefferson Medical College, Senior Vice President and Chief Medical Officer, Thomas Jefferson University 1:00 PM - 2:00 PM |
|
| 2:00 PM |
Panel: The Interplay of Economic and Clinical Issues Judith K. Jones, MD, PhD., President and CEO, Degge Group, Ltd. 2:00 PM - 2:10 PM |
|
| 2:10 PM |
Panel: The Interplay of Economic and Clinical Issues Laurence J. Kotlikoff, Professor of Economics, Boston University 2:10 PM - 2:30 PM |
|
| 2:30 PM |
Panel: The Interplay of Economic and Clinical Issues R. Terry Hisey, Vice Chairman, U.S. Life Sciences Leader, Deloitte LLP 2:30 PM - 2:45 PM |
|
| 2:45 PM |
Panel: The Interplay of Economic and Clinical Issues (Question and Answer session with entire panel) Judith K. Jones, MD, PhD, President & CEO, Degge Group, Ltd. 2:45 PM - 3:00 PM |
|
